What it is used for

For the treatment of relapsing forms of multiple sclerosis. In patients who have experienced a single demyelinating event and are at risk of developing clinically definite multiple sclerosis based on the presence of brain MRI abnormalities characteristic of multiple sclerosis.

How to take it

The way to take this medicine is: Intramuscular. This medicine is given through a needle inserted into the muscle beneath the skin.

• Store at 2 to 8 degrees Celsius
• Protect from Light
• Do not Freeze
• Shelf lifetime is 3 Years.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.

Visual appearance

Clear colourless solution in a type I glass syringe barrel with ceramic coated tip, grey elastomeric stopper and grey ribbed plastic cap, a blue 23G 1 1/4 needle and a plunger rod, sealed in a blister tray.

Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine. open tool tip to find out more

Is this medicine subsidised?

This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.

Pregnant or planning a pregnancy?

For the active ingredient interferon beta-1a

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.